Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 1
Graphical abstract
Section snippets
Acknowledgments
This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) (H.T.), and by a grant-in-aid for Scientific Research (B) 18390008 (H.T.). The authors thank the following groups: Meiji Seika Pharma Co., Ltd. for their extensive cooperation; ChemGenesis and PharmaDesign, Inc. for their valuable advice; and Chemical Analysis Center (Kitasato Univ., Ms. Sato and Dr. Nagai) for kindly measuring NMR and MS
References and notes (28)
Drug Discovery Today
(1998)- et al.
Pharmacol. Ther.
(2007) - et al.
Bioorg. Med. Chem. Lett.
(1995) - et al.
J. Biol. Chem.
(1993) - et al.
J. Biol. Chem.
(1998) - et al.
J. Biol. Chem.
(1998) - et al.
J. Biol. Chem.
(1998) - et al.
J. Lipid Res.
(2004) - et al.
- et al.
J. Antibiot.
(1993)
J. Antibiot.
(1994)
J. Antibiot.
(1994)
J. Antibiot.
(1995)
J. Antibiot.
(1996)
Cited by (0)
Copyright © 2013 Elsevier Ltd. All rights reserved.